This joint session, held in tandem with SCCM, is an essential session for all healthcare practitioners who have dealt with or may encounter sepsis in their institutions. Six internationally respected speakers will present on a range of topics aimed at allowing participants to review the recently published Surviving Sepsis Guidelines and understand the evidence behind the guidelines. These experts will appraise and critically discuss the controversial aspects and provide a conceptual and practical overview of what will come next in the campaign.  

Chaired by ESICM President Jean-Daniel Chiche and SCCM President Carol Thompson, this session will cover all the basis of the Surviving Sepsis Campaign: past, current and future. Mitchell Levy will describe how to use a limited evidence base to guide clinical  practice, while Richard Beale will guide participants on the revised bundle system, including how and why they should be part of best sepsis practice. In his presentation, Derek Angus will delve deeper into the controversy behind some of the bundle elements.

Jan De Waele will highlight infection source control (ISC) in his presentation. He notes that ISC is a key element in sepsis treatment, and probably the most challenging part once an infection focus amenable for ISC has been identified. Currently ISC is not a priority in the SSC guidelines, and recommendations remain vague, presumably due to a lack of data on the exact role of ISC, and the complexity of ISC procedures. This makes ISC one of the areas where significant advances are urgently required to improve outcome of severe sepsis and septic shock patients.  

In order to accomplish this, studies in this field need to better describe source control interventions, as well as the timing and efficacy thereof. The role of new ISC interventions such as percutaneous drainage should be properly studied in rigorously designed interventional studies. Furthermore, the potential role of a dedicated multidisciplinary ISC team, including a surgeon and interventional radiologist among others, should be explored.

PHOTO: Speaker Jan De Waele (ESICM Infection Section)

Until we have more information, the need for ISC measures should be considered in all severe sepsis patients, and when required, should not be delayed - not even a few hours - unless patient physiology is considered unfit for the intervention, or in specific circumstances eg infected pancreatic necrosis. Institutions that treat these patients require 24/7 access to diagnostic and interventional imaging as well as surgery.  

Some key messages to be taken from this focus on infection: 

  • SSC recommendations give little guidance regarding  infection source control interventions
  • Infection source control is essential and should be considered in all severe sepsis patients
  • Clinical studies in severe sepsis and septic shock need to report ISC methodology and efficacy
  • For most patients, there is no advantage in delaying ISC interventions 
  • New concepts such as dedicated ISC teams may improve effective ISC implementation
This informative and comprehensive session on the SSC campaign should be on every clinicians congress agenda...


Monday October 7th 2013, 16:00 - 18:00, Room Paris

<Back to the news list
Comment on this news Comment on this news
To respond to this article, thank you for identifying
ReactionsReactions (0)